Tribunal upholds CMA’s decision to fine Lexon £1.2m
Company found to have broken competition law to drive up prices of antidepressant nortriptyline
Read More
Tag: price collusion
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
